Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-03

FDA Approved: PRAZOSIN HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original application for prazosin hydrochloride (generic), enabling its marketing as a generic treatment for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin hydrochloride (prazosin hydrochloride)

Snippet

ORIG AP for PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)